FutureSight
HealthTech
Co-Founder&CEO
Neural analysis suggests this role is
optimal for Founder candidates.
“Co-Founder & CEO at FutureSight. Skills: Strategy, Customer Development, Product Management, Capital Raising, Team Leadership. Set venture's direction. Lead execution”
Industry & Context.
What They're Looking For.
Must Have
Previous founding experience at a venture-backed company, Demonstrated success in B2B SaaS go-to-market, including sales and customer engagement, Fundraising fluency, with the ability to develop investor narratives and close capital, Proven ability to attract, develop, and retain top talent, Clear-eyed understanding of the risks and demands of co-founding a venture-backed company, Deep, operational exposure to healthcare revenue cycle, medical billing, or denial management, Intuitively understand the operational differences between clinical/coding denials and administrative roadblocks, Familiar with the fragmented realities of smaller EHR/PM systems and the "band-aid" tech stacks billers use to survive
What You'll Do.
Set venture's direction
Refine product positioning
Convert leads to paid engagements
Build go-to-market motion
Iterate on user feedback
Recruit founding team
Establish cultural foundation
How You'll Work.
Team & Collaboration
Partner with FutureSight product and engineering team
Full Job Description
### The Opportunity FutureSight is seeking a Co-Founder & CEO to lead Clairo, an AI-native clinical documentation compliance venture currently in build at our studio. This is a co-founder partnership with meaningful founder equity, not a salaried executive role. Clairo AI audits 100% of healthcare charts in real-time, catches payer-specific gaps before they hit billing, and eliminates the manual QA overhead that costs organizations millions in denials and clawbacks every year. Currently, manual QA teams consume 25%+ of operational labour budgets, yet audit only about 10% of patient charts, leaving organizations massively exposed. ### Market Context We didn't just build a thesis; we validated it directly with the market. We have spoken directly with Compliance Directors, QA Leaders, and Revenue Cycle Directors across behavioural health organizations. The market signal is incredibly strong: * Unprompted Product Pull: Every single lead described the exact product we want to build: a pre-billing, real-time, EHR-integrated flagging layer that checks documentation against payer-specific rules before claims are submitted. * Massive Financial Pain: The real pain comes from post-payment recoupments (clawbacks). Buyers cited chronic, aggressive payer audits happening weekly or monthly, with single audit events causing catastrophic losses ranging from $150,000 to $850,000. * Budget is NOT the Blocker: Buyers explicitly stated that if the tool integrates cleanly with their EHR and meets a high accuracy bar, securing the budget is not a problem. We are targeting a large, highly fragmented market where revenue cycle teams are increasingly struggling to manage denials at scale. The total addressable market is estimated at $4.0B–$6.0B+, spanning more than 20,000 organizations, including multispecialty groups, behavioural health providers, and health systems. The ROI case is compelling: at current price points, the software can quickly pay for itself by reducing manual auditing labo
Applying for this Co-Founder & CEO role?
Most applicants get filtered before a human reads their resume. See if yours makes the cut.
ANONYMOUS · UNFILTERED
What do employees actually say about FutureSight?
Real rants from real employees. Read before you apply.